FMP

FMP

Enter

AXGN - AxoGen, Inc.

photo-url-https://images.financialmodelingprep.com/symbol/AXGN.png

AxoGen, Inc.

AXGN

NASDAQ

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

14.86 USD

0.02 (0.135%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Mr. Nir Naor C.F.A., CPA, L.L.M., M.B.A.

sector

Healthcare

industry

Medical - Devices

exchange

NASDAQ

Description

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attac...

CIK

0000805928

ISIN

US05463X1063

CUSIP

05463X106

Address

13631 Progress Boulevard

Phone

386 462 6800

Country

US

Employee

426

IPO Date

Dec 17, 1986

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

AXGN Financial Summary

CIK

0000805928

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

05463X106

ISIN

US05463X1063

Country

US

Price

14.86

Beta

1.13

Volume Avg.

378.02k

Market Cap

653.96M

Shares

-

52-Week

5.55-15.9

DCF

11.66

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-45.03

P/B

-

Website

https://www.axogeninc.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest AXGN News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep